Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Randomized Phase II and Biomarker Study of Pembrolizumab Plus Bevacizumab Versus Pembrolizumab Alone for Recurrent Glioblastoma PatientsClin. Cancer Res 2020 Nov 16;[EPub Ahead of Print], L Nayak, AM Molinaro, KB Peters, JL Clarke, JT Jordan, JF de Groot, PL Nghiemphu, TJ Kaley, H Colman, C McCluskey, S Gaffey, T Smith, DJ Cote, M Severgnini, JH Yearley, Q Zhao, WM Blumenschein, DG Duda, A Muzikansky, RK Jain, PY Wen, DA Reardon
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.